We are pleased to announce the entry of the Galia Gestion fund and the majority entry by the historical management, Mr. Arnaud Cardinet in the capital of Gabilly (now Lyamtech).
The Gabilly company is specialized in a niche of diagnosis, manufacturing and support in light medical devices. It is mainly aimed at patients with reduced mobility on medical prescription. Gabilly is one of the major players in its segment.
It can now support the very high development potential of its offer. This potential is deployed through the development of a network, the enlargement of a range, and the exploitation of new innovative technologies.
I-Deal Development was able to meet the expectations of Gabilly’s managers by taking into account the complexity of the shareholding and the interests of the family context. A development strategy was built alongside the manager, focusing on the intrinsic characteristics of the market.
The Galia fund, an equity investor, is a privileged shareholder of regional companies on a “human” scale, with a strategy of minority support.
While allowing the current manager to focus on his business, I-Deal Development was able to build a tailor-made solution with the managers of Gabilly and Galia (new shareholder).
